The present invention relates to assay readers, in particular but not limited to optical modules for assay readers.
Diagnostic tests are commonly used for identifying diseases. A diagnostic test may be carried out in a central laboratory, whereby a sample, for example blood, is taken from a patient and sent to the central laboratory where the sample is analysed. A different setting for processing samples is at the point where care for the patient is delivered, which is referred to as point-of-care (POC) tests. POC tests allow for a faster diagnosis. Within the POC tests, different technology platforms can be used. A first class of POC tests are high end, microfluidic-based POC tests. These POC tests are mainly used in a professional environment such as hospitals or emergency rooms. A different technology platform is provided by lateral flow test technology. Some lateral flow tests are used in the consumer area, such as for pregnancy tests, and are easy to produce and very cost-effective.
Lateral flow tests are very well known as such, but are briefly described by way of background. A lateral flow assay includes a series of capillary beds, such as pieces of porous paper, nitrocellulose membranes, microstructured polymer, or sintered polymer for transporting fluid across a series of pads by capillary forces. A sample pad acts as a sponge and is arranged to receive a sample fluid, and further holds an excess of the sample fluid. After the sample pad is saturated with sample fluid, the sample fluid migrates to a conjugate pad in which the manufacturer has stored the so-called conjugate. The conjugate is a dried format of bio-active particles in a salt-sugar matrix intended to create a chemical reaction between the target molecule (e.g., an antigen) and its chemical partner (e.g. antibody or receptor). While the sample fluid dissolves the salt-sugar matrix, it also mobilizes the bio-active particles and in one combined transport action the sample and conjugate mix with each other while flowing through the capillary beds. The analyte binds to the particles while migrating further through the third capillary bed. This material has one or more areas, which are called stripes, where a third type of molecule has been immobilized by the manufacturer, in most cases an antibody or receptor addressed against another part of the antigen. By the time the sample-conjugate mix reaches these strips, analyte has been bound on the particle and the third type of molecule binds the complex. When more fluid has passed the stripes, particles accumulate on the stripes and the stripes become visible, appear or are generated in a particular colour or with a fluorescent wavelength capability. In this way the stripe is optically detectable by colour or by fluorescent emission detection, respectively.
Typically, there are at least two stripes: a control stripe/line that captures the conjugate and thereby shows that reaction conditions and technology work, and a second stripe, the test stripe/line, that contains a specific capture molecule and only captures those particles onto which an analyte or antigen molecule has been immobilized. This makes the diagnostic result of the test visible for the patient. Some test results rely on the presence of fluorescent particles, which may not be visible to the user but can instead be detected by optical detectors when the stripes are illuminated. After passing the different reaction zones, the fluid enters the final porous material, which is a wick that acts as a waste container.
The lateral flow test strip can contain multiple test lines, where each test line contains a different type of specific capture molecule, which binds to a different analyte or antigen. This multi-analyte detection, using spatially separated test lines, can be done using the same colour or fluorescent emission wavelength for the optical detection. However, each test line can also be made visible by different colours or fluorescent emission wavelength. For example, each type of specific receptor bound to its respective analyte-conjugate complex may have a different colour or emission wavelength. Ultimately, these test lines can be one line, not spatially separated, on the lateral flow test strip, but can be spectrally separated by the different colours or emission wavelengths.
In summary, lateral flow tests as such are well known and have four key elements: the antibody, the antigen, the conjugate and the complex. Despite these key elements being well established, the terminology used by the skilled person is not always consistent and different terms may refer to the same element. The antibody is also referred to as receptor, chemical partner, or capture molecule. The antigen is also referred to as analyte, target molecule, antigen molecule, target analyte or biomarkers. The sample typically contains the analyte, although that is not always the case. The conjugate is also referred to as (analyte) tags, tagging particles, chemical partner, (sample) conjugate mix, bioactive particles or conjugate receptors. Examples of conjugates are fluorescent particles, red particles or dyes, and further examples are provided in the specific description. The complex is the combination of the antigen and conjugate. The complex is also referred to as tagged analyte, or particles onto which the analyte molecule has been immobilised.
Currently, there are lateral flow tests available that you can “read” with your naked eye. The most commonly known test is the pregnancy test that one can buy in a supermarket or pharmacy. These tests indicate if a certain analyte (e.g. HCG hormone in the case of a pregnancy test) is above a certain value or below a certain value. No quantification is possible and the sensitivity is limited to the colour difference one can observe with its naked eye. In addition, since it has to be visible with the naked, only conjugates (e.g. dyes) in the visible region can be used.
To increase the sensitivity and the level of quantification, electronic optical detectors exist where a lateral flow test strip is positioned with a light source and an optical detector. The electronic optical detector may be incorporated into a lateral flow assay device comprising the lateral flow test strip. Alternatively, the electronic optical detector may be incorporated into an assay reader device comprising an aperture for receiving a lateral flow assay device, the lateral flow assay device comprising the lateral flow test strip.
The inventors have identified that with known electronic optical detectors 1) the sensitivity is often hampered by the auto-fluorescent background signal and 2) multi-analyte detection is difficult, since additional light sources and detectors are needed in order to measure different kinds of analytes e.g. different kind of lines. In addition, many of the lateral flow tests use dyes in the visible wavelength band for detection since it is visible to the naked eye. However, many biological liquids and even the membrane have their autofluorescence in the visible region when excited by visible or ultraviolet (UV) light, which attributes to high background signal.
Fluorescence is an event whereby a substance absorbs energy from an electromagnetic radiation and emits light at a lower/higher energy than the absorbed energy. A lot of organic substances present on the fluids and/or the LFT-paper has fluorescence when it is excited with light, which is a natural occurrence, this is termed autofluorescence.
In a detection assay, a conjugate (e.g. an artificial fluorophore) is used to detect the concentration of a particular compound. However, autofluorescence of other natural compounds (such as human skin, blood, urine, plasma, nitrocellulose membrane etc.) also give out fluorescence at wavelengths that are the same as the desired detection. For instance, porphyrins in plasma autofluoresce at 590 nm and 630 nm, and nitrocellulose membranes autofluoresce at 500 nm and 600 nm. This in turns reduce the sensitivity, as it is considered as background noise with respect to the marker signal.
Embodiments of the present disclosure generally relate to an optical module which reduces the background autofluorescence when analysing a lateral flow test strip. This results in an increase of sensitivity by two to three orders of magnitude. This high sensitivity allows detection of biomarkers (and thus the corresponding diseases) previously not possible with eye-read lateral flow tests.
According to one aspect there is provided an optical module for reading a test region of an assay, the optical module comprising: a near-infrared light source for illuminating the test region of the assay with light in a near-infrared spectrum; an optical detector, comprising an optical input for receiving light emitted from the test region of the assay and an electrical output; an electrical signal processor, electrically coupled to the electrical output; and one or more optical filter arranged in front of the optical input of the optical detector.
This allows for very sensitive and quantitative measurements to be performed by the electrical signal processor.
The optical module may comprise a plurality of optical filters. This advantageously enables multiple analytes to be detected and measured without the need for additional lines or more detectors.
The plurality of optical filters may correspond to a plurality of spatially separated regions of the optical detector.
The optical detector may comprise an array of detectors, and wherein each detector of the array of detectors may correspond to each of said optical filters.
The one or more optical filter may be arranged in front of the optical input of the optical detector such that there is no spectral filter in front of a portion of the optical input. This enables the electrical signal processor to check the background light, to check the light intensity of the near-infrared light source, to check a reference area on the strip/membrane of the assay, or to check if there are an ambient light leaking into the detection system.
In some embodiments, the optical detector comprises the one or more optical filter.
The optical module may comprise a second near-infrared light source for illuminating a control region of the assay.
In some implementations, the optical filters are configured to enable the electrical signal processor to measure the absorption of the excitation wavelength due to the fluorescence properties of the conjugate used in the assay. In these implementations, the light emitted by the near-infrared light source has an excitation spectrum centred on an excitation wavelength and the one or more optical filter is transparent to at least a portion of said excitation spectrum, wherein said portion of the excitation spectrum is within an absorption spectrum of a conjugate used in said assay. The one or more optical filter may be configured to block light having wavelengths within an emission spectrum of said conjugate.
In other implementations, the optical filters are configured to enable the electrical signal processor to measure the emission of the fluorescence of the conjugate used in the assay. In these implementations, the light emitted by the near-infrared light source has an excitation spectrum centred on an excitation wavelength and the one or more optical filter is transparent to wavelengths within an emission spectrum of a conjugate used in said assay.
The wavelengths within the emission spectrum of the conjugate used in said assay may be at a higher wavelength than the excitation spectrum. Alternatively, the wavelengths within the emission spectrum of the conjugate used in said assay may be at a lower wavelength than the excitation spectrum. The fluorescence emission is too weak to trigger much autofluorescence, or it is negligible. In these implementations the optical module acts as an anti-stoke fluorescent reader. The wavelengths within the emission spectrum of the conjugate used in said assay may be in the visible spectrum or in the near-infrared spectrum.
In these other implementations the one or more optical filter may block light having wavelengths within the excitation spectrum of the infrared light source.
The optical module may further comprise a substrate for mounting the near-infrared light source and the optical detector. The electrical signal processor may be mounted on the substrate.
The substrate may comprise a printed circuit board of an assay reader device, or the substrate may be configured to be positioned on a printed circuit board of an assay reader device.
According to another aspect of the present disclosure there is provided an assay reader device comprising the optical module described herein.
The assay reader device may comprise a lateral flow test strip. That is, both the optical module and the lateral flow test strip may be packed into a single assay reader device. In these embodiments, the distance between the site of the colour change and the optical detector is very small which avoids a decreased signal or the need to use a more expensive or sensitive detector.
Alternatively the assay reader device comprises an aperture for receiving a lateral flow assay device comprising a lateral flow test strip. In these embodiments the lateral flow assay device comprising the lateral flow test strip is inserted into the aperture for the optical module to analyse the test lines on the lateral flow test strip.
According to another aspect of the present disclosure there is provided a method for reading a test region of an assay, the method comprising: illuminating the test region with a near-infrared light source that is operable to emit light in a near-infrared spectrum; providing the test region of the assay in the field of view of an optical detector; filtering light emitted from the test region using one or more optical filter to provide filtered light; and detecting the filtered light with the optical detector.
These and other aspects will be apparent from the embodiments described in the following. The scope of the present disclosure is not intended to be limited by this summary nor to implementations that necessarily solve any or all of the disadvantages noted.
Some embodiments of the disclosure will now be described by way of example only and with reference to the accompanying drawings, in which:
Embodiments will now be described by way of example only with reference to the accompanying figures.
Lateral flow assays or other types of assays indicate the presence of a target molecule by the change of colour characteristics of a test region of the assay.
As noted above, the inventors have identified that other natural compounds exhibit autofluorescence at wavelengths within the visible range. For example, for natural compounds, such as human skin, blood, urine, plasma, nitrocellulose membrane, the autofluorescence emission is in the visible range 400 nm to 600 nm when excited with a shorter wavelength 300 nm to 500 nm. This autofluorescence (coming from non-dye or non-marker related material) acts as background noise with respect to the marker signal. Embodiments of the present disclosure are directed to reducing this background noise.
The at least one NIR light source 13 emits NIR light in the 700-2500 nm wavelength range. The at least one NIR light source 13 may be a pulsed or continuous light source.
Arranged on the substrate 11 is also one or more walls 16 which divide the space between the substrate 11 and the lateral flow test strip 15 into a plurality of adjoining sections, and which may fully or partially enclose the one or more light sources 13 and optical detector 12 to shield the optical detector 12 from light outside of the walls 16. The one or more walls 16 may optionally comprise light absorbing material to reduce unwanted noise caused by e.g. stray reflections inside the walls 16.
One or more of the walls 16 may comprise an aperture 17 to provide an optical path from the at least one light source 13 and optical detector 12 inside the walls 16 to the lateral flow test strip 15 outside the walls 16. The number of apertures 17 may determine how many test lines or zones may be simultaneously read. Where multiple apertures 17 are present, it is envisaged that multiple light sources 13 may be used. In the non-limiting example of
Alternatively and/or additionally, one or more of the walls 16 may be arranged to block a portion of the field of view of the detector 12. For example, a wall 16a may be positioned between the optical detector 12 and the light source 13 so that the light source is not in the direct field of view of the optical detector 12. Instead light from the light source 13 only indirectly reaches the optical detector 12 through reflections and/or emissions from the lateral flow test strip 15. This ensures the optical detector 12 is not swamped by direct illumination and noise is thereby reduced.
Alternatively and/or additionally, in the case where multiple apertures 17 are present, one or more of the walls 16b may be arranged to prevent light from one aperture 17 interfering with light from the others at the optical detector 12, which may otherwise cause unwanted noise. For example, the walls 16 may be arranged such that the optical path from one aperture 17 does not intersect that of another. The walls 16 are thus arranged to control what light from different apertures 17 reaches different spatially separated regions of the optical detector 12.
One or more optical filter 10 is used in the detection of the presence of an analyte 14 on the test lines or zones on the lateral flow test strip 15. For multi-analyte detection, multiple optical filters 10 are used to discriminate between a plurality of different possible changes of the test line of the assay. The optical filter(s) 10 may be external to the optical detector 12, or the optical detector 12 may be wavelength sensitive and thereby include the optical filter(s) 10. The optical detector can be an array of photodiodes, whereby one or more of the photodiodes may have a corresponding optical filter provided in front thereof to thereby control what wavelength of light is received by the respective photodiode. One or more photodiodes may also be provided with a clear filter C or no filter. The array of photodiodes can be part of one or more ASICS.
The optical detector 12 is arranged with respect to the test region such that the test region is in the field of view of the optical detector 12. The NIR light source 13 may be arranged outside the field of view of the optical detector 12 to minimise noise that might otherwise be caused by direct illumination of the optical detector 12 with the light source 13. Additionally, or alternatively, noise caused by the reflectance of areas around the test and control lines on the lateral flow test strip can be reduced by minimising this reflectance. This may be achieved, for example, by arranging one or more optical components such as diaphragms, slits, walls, and/or other blocks in the optical path between the test region and the optical detector to reduce and/or block undesired light reflected from the areas around the test and control lines from reaching the optical detector. The test region may be on-axis or off-axis for the field of view of the detector. A planar optical detector may be used. For the optical detector 12 is it possible to use silicon, Si, (700-1150 nm); indium gallium arsenide, InGaAs, (−1600 nm); or germanium, Ge, and germanium-tin (1.4 um-2.4 um).
The test region of the assay may be a flow membrane with reaction regions, for example reaction lines, but the reaction region on the membrane may also be in the form of a circle, dot, or any other shape. Moreover, the reaction region can be a matrix of dots or can be referred to in general as test sites. The test region, which can accommodate multiple analytes, combined with the array of different optical filters enables simultaneous detection of multiple analytes. The signal can also be time resolved to detect reaction dynamics.
Exemplary configurations of the above techniques will now be described. These configurations are not intended to be limiting and it is envisaged that elements of each configuration may be combined with each other.
In order to reduce background noise, one or more of three methods may be employed by the optical module 100 to avoid background noise caused by autofluoroescence:
In particular
When the sample region is illuminated with the excitation spectrum 502 of light emitted by the NIR light source 13 the sample will emit light at one or more longer wavelengths than the excitation wavelength (when a downconverting dye is used).
The first method described above uses absorption/reflection of light. The test region is illuminated with the NIR light source 13 and the reflected spectrum and its intensity (quantification) depends on the presence of analytes.
As shown in
As shown in
As illustrated in
The filter response 512 may have a stop-band that includes wavelengths of light in the emission spectrum 506 exhibited by the conjugate. That is, the optical filter(s) are configured to block wavelengths of light in the emission spectrum 506 exhibited by the conjugate. In these implementations, the one or more optical filter 10 may be configured as low-pass or band pass filters.
When multiple different analytes are present, multiple different absorption spectrums can be monitored. This is illustrated in
In the first method, the processing logic of the electrical signal processor 5 measures a signal indicative of the amount of absorption of light due to an analyte in the conjugate. The processing logic can use a reference threshold to provide a binary outcome, whereby a positive test result is provided if the measured signal is above the threshold (noting that low reflection corresponds to high absorption which is indicative that a target analyte is present) and whereby a negative test result is provided if the measured signal is below the threshold (noting that high reflection corresponds to low absorption which is indicative that a target analyte is not present). However, the processing logic is alternatively able to quantify the strength of the signal.
The second method described above uses fluorescence. As noted above when the sample region is illuminated with the excitation spectrum 502 of light emitted by the NIR light source 13 the sample will emit light at one or more longer wavelengths than the excitation wavelength (when a downconverting dye is used).
As shown in
In these implementations, the one or more optical filter 10 may be configured as high-pass or band pass filters.
In the second method, the processing logic of the electrical signal processor 5 takes a fluorescence measurement of the signal output by the optical detector 12. The processing logic can use a reference threshold to provide a binary outcome, whereby a positive test result is provided if the measured signal is above the threshold and whereby a negative test result is provided if the measured signal is below the threshold. However, the processing logic is alternatively able to quantify the strength of the signal.
A small disadvantage with the first method over the second method is a slight loss of dynamic range but with an increase of signal-to-noise ratio. The loss in dynamic range is due to the excitation wavelength of the excitation spectrum 502 of light emitted by the NIR light source 13 being at the flank of the absorption spectrum 504 compared to being at the peak of the absorption spectrum 504. The inventors have identified that by using near-infrared fluorescent dye that has a much more distinctive difference between absorption wavelength and emission wavelength, the loss of dynamic range can be mitigated.
When using the first method or the second method the NIR light source does not excite the autofluorescence of materials within the assay. Furthermore the optical detector 12 detects wavelengths of filtered light that are distant from the autofluorescence wavelengths of materials within the assay. This reduces the background noise and increases the analytical sensitivity of the measurements performed by the electrical signal processor 5.
Whilst in the second method referred to above a downconverting dye is used, in the third method an upconverting dye is used such when the sample region is illuminated with the excitation spectrum 502 of light emitted by the NIR light source 13 the sample will emit light at one or more shorter wavelengths than the excitation wavelength. In the third method the optical module 100 acts an anti-stoke fluorescent reader.
The excitation spectrum 702 is centred on an excitation wavelength λ1 in the NIR wavelength range which in the example shown in
When the sample region is illuminated with the excitation spectrum 702 of light emitted by the NIR light source 13 the sample will emit light at one or more shorter wavelengths than the excitation wavelength (when an upconverting dye is used).
When employing the third method, the optical filter(s) are configured to be transparent to wavelengths associated with the emission spectrum 706 exhibited by the conjugate and block all other, or at least the excitation wavelengths.
In the third method, the processing logic of the electrical signal processor 5 takes a fluorescence measurement of the signal output by the optical detector 12. The processing logic can use a reference threshold to provide a binary outcome, whereby a positive test result is provided if the measured signal is above the threshold and whereby a negative test result is provided if the measured signal is below the threshold. However, the processing logic is alternatively able to quantify the strength of the signal.
When using the third method the NIR light source does not excite the autofluorescence of materials within the assay. Furthermore the emission spectrum 706 may be in the near-infrared spectrum such that the optical detector 12 detects wavelengths of filtered light that are distant from the autofluorescence wavelengths of materials within the assay. The emission spectrum 706 may also be in the visible spectrum, even in these implementations the fluorescence emission is too weak to trigger much autofluorescence, or it is negligible. Thus the third method also reduces the background noise and increases the analytical sensitivity of the measurements performed by the electrical signal processor 5.
In some embodiments of the present disclosure, the optical module 100 described herein is incorporated into an assay reader device 800 shown in
In other embodiments of the present disclosure, the optical module 100 described herein is incorporated into an assay reader device 800 shown in
Although the disclosure has been described in terms of preferred embodiments as set forth above, it should be understood that these embodiments are illustrative only and that the claims are not limited to those embodiments. Those skilled in the art will be able to make modifications and alternatives in view of the disclosure which are contemplated as falling within the scope of the appended claims. Each feature disclosed or illustrated in the present specification may be incorporated in any embodiments, whether alone or in any appropriate combination with any other feature disclosed or illustrated herein.
| Number | Date | Country | Kind |
|---|---|---|---|
| 2019772.9 | Dec 2020 | GB | national |
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/EP2021/085546 | 12/13/2021 | WO |